药物对比
比较Erenumab（Aimovig）与Nefopam。Erenumab通过阻断CGRP预防偏头痛；Nefopam是用于急性疼痛的非阿片类药物。两者在用途和安全性方面的主要差异。
此页面暂无可用的对比维度。
临床背景
This comparison occurs when evaluating options for migraine prophylaxis versus acute non-opioid pain relief.
结论
Erenumab and Nefopam serve distinct roles and cannot be ranked as one being better overall.